Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.

Tytuł:
Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.
Autorzy:
Su D; Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, CA, USA.
Hooshmand MJ; Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, CA, USA.; Institute for Memory Impairments and Neurological Disorders (iMIND), University of California, Irvine, Irvine, CA, USA.; Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA.
Galvan MD; Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, CA, USA.
Nishi RA; Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA.
Cummings BJ; Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, CA, USA.; Institute for Memory Impairments and Neurological Disorders (iMIND), University of California, Irvine, Irvine, CA, USA.; Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA.; Department of Physical Medicine and Rehabilitation, University of California, Irvine, CA, USA.
Anderson AJ; Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, CA, USA. .; Institute for Memory Impairments and Neurological Disorders (iMIND), University of California, Irvine, Irvine, CA, USA. .; Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA. .; Department of Physical Medicine and Rehabilitation, University of California, Irvine, CA, USA. .
Źródło:
Scientific reports [Sci Rep] 2020 Nov 11; Vol. 10 (1), pp. 19500. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
MeSH Terms:
Complement C6/*deficiency
Hereditary Complement Deficiency Diseases/*complications
Spinal Cord Injuries/*metabolism
Spinal Cord Injuries/*physiopathology
Animals ; Behavior, Animal ; Complement C6/genetics ; Complement Membrane Attack Complex/genetics ; Complement Membrane Attack Complex/metabolism ; Disease Models, Animal ; Female ; Genotype ; Glial Fibrillary Acidic Protein/metabolism ; Gray Matter/cytology ; Gray Matter/metabolism ; Hereditary Complement Deficiency Diseases/genetics ; Heterozygote ; Locomotion ; Male ; Myelin Basic Protein/metabolism ; Rats, Mutant Strains ; Selective Breeding ; Spinal Cord Injuries/etiology ; Spinal Cord Injuries/genetics ; Thoracic Vertebrae/injuries ; White Matter/cytology ; White Matter/metabolism
References:
Infect Immun. 2000 Mar;68(3):1626-32. (PMID: 10678982)
Clin Exp Immunol. 1997 Aug;109(2):387-96. (PMID: 9276537)
Curr Neuropharmacol. 2009 Mar;7(1):1-8. (PMID: 19721814)
Brain Behav Immun. 2017 Nov;66:31-44. (PMID: 28526435)
Kidney Int. 1997 Dec;52(6):1570-8. (PMID: 9407502)
J Immunol. 2000 Nov 15;165(10):5867-73. (PMID: 11067947)
Am J Pathol. 1997 Jun;150(6):2019-31. (PMID: 9176395)
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2235-40. (PMID: 26858424)
J Neurol Sci. 1989 Feb;89(2-3):289-300. (PMID: 2926453)
Neuropathol Appl Neurobiol. 2004 Feb;30(1):80-9. (PMID: 14720179)
J Neuroimmunol. 2009 Aug 18;213(1-2):3-11. (PMID: 19577811)
Proc Natl Acad Sci U S A. 1989 Nov;86(22):9025-9. (PMID: 2813437)
Sci Rep. 2017 Oct 10;7(1):12904. (PMID: 29018286)
Kidney Int. 1995 Jun;47(6):1604-14. (PMID: 7643529)
Eur J Clin Invest. 2010 Jan;40(1):4-10. (PMID: 19843156)
Indian J Med Res. 2012 Mar;135:287-96. (PMID: 22561613)
Infect Immun. 2006 May;74(5):2803-8. (PMID: 16622217)
Immunol Res. 2011 Oct;51(1):45-60. (PMID: 21850539)
Arthritis Rheum. 2007 Apr;56(4):1187-97. (PMID: 17393439)
Am J Pathol. 2010 Dec;177(6):2685-7. (PMID: 20952586)
Neuroscience. 2011 Aug 11;188:109-16. (PMID: 21575686)
J Neuroinflammation. 2011 Aug 30;8:109. (PMID: 21878125)
J Immunol. 2009 Nov 15;183(10):6041-50. (PMID: 19841183)
J Immunol Methods. 1989 Dec 20;125(1-2):147-58. (PMID: 2607149)
Brain. 2010 Feb;133(Pt 2):433-47. (PMID: 20085927)
Glia. 2000 Apr;30(2):187-98. (PMID: 10719360)
J Neuroimmunol. 1993 Nov-Dec;48(2):169-75. (PMID: 7693753)
Neuron. 1994 Oct;13(4):805-11. (PMID: 7524558)
J Neurotrauma. 2006 Jan;23(1):36-54. (PMID: 16430371)
J Neuroimmunol. 2010 Dec 15;229(1-2):98-106. (PMID: 20850187)
Immunol Rev. 2001 Apr;180:49-55. (PMID: 11414362)
Neuroreport. 1998 Mar 30;9(5):927-32. (PMID: 9579692)
J Am Soc Nephrol. 1999 Nov;10(11):2323-31. (PMID: 10541291)
J Neurochem. 2008 Dec;107(5):1169-87. (PMID: 18786171)
J Neurosci. 2008 Dec 17;28(51):13876-88. (PMID: 19091977)
J Comp Neurol. 2006 Feb 1;494(4):578-94. (PMID: 16374800)
J Immunol. 2007 Jul 1;179(1):172-8. (PMID: 17579035)
J Immunol. 2002 May 1;168(9):4293-300. (PMID: 11970970)
Behav Brain Res. 2006 Apr 3;168(2):272-9. (PMID: 16406145)
Kidney Int. 2005 Feb;67(2):492-503. (PMID: 15673297)
J Exp Med. 2016 Nov 14;213(12):2603-2620. (PMID: 27810921)
Clin Exp Immunol. 1994 Sep;97(3):478-82. (PMID: 8082303)
Neuropathol Appl Neurobiol. 1986 Nov-Dec;12(6):593-605. (PMID: 3561693)
Mol Immunol. 2010 Feb;47(5):1098-105. (PMID: 19959238)
Exp Neurol. 1999 Oct;159(2):362-76. (PMID: 10506508)
Glia. 2000 Jan 1;29(1):102. (PMID: 10594929)
J Neurotrauma. 1995 Feb;12(1):1-21. (PMID: 7783230)
J Comp Neurol. 1997 Jan 20;377(3):443-64. (PMID: 8989657)
Kidney Int. 1996 Feb;49(2):335-43. (PMID: 8821815)
Biochem J. 1989 Nov 15;264(1):1-14. (PMID: 2690818)
Am J Pathol. 2010 Dec;177(6):3061-70. (PMID: 20952585)
Immunol Res. 2005;31(1):37-46. (PMID: 15591621)
J Comp Neurol. 2002 Sep 23;451(3):225-35. (PMID: 12210135)
Pathol Res Pract. 2008;204(6):373-8. (PMID: 18339486)
Acta Neuropathol. 1995;89(4):322-30. (PMID: 7610763)
Am J Pathol. 2006 Sep;169(3):1039-47. (PMID: 16936276)
J Immunol. 2001 Aug 15;167(4):2305-11. (PMID: 11490019)
J Am Soc Nephrol. 1999 Jun;10(6):1242-52. (PMID: 10361862)
J Neurotrauma. 2018 Dec 15;35(24):2924-2940. (PMID: 29877129)
Acta Neurobiol Exp (Wars). 2011;71(2):281-99. (PMID: 21731081)
J Neurotrauma. 2006 May;23(5):635-59. (PMID: 16689667)
J Neurosci. 2007 Jul 18;27(29):7663-72. (PMID: 17634361)
J Rehabil Res Dev. 2006 Jan-Feb;43(1):123-32. (PMID: 16847778)
Neuron. 1994 Sep;13(3):757-67. (PMID: 7522484)
Acta Neuropathol Commun. 2017 Feb 17;5(1):15. (PMID: 28212662)
J Immunol. 2002 Jan 1;168(1):458-65. (PMID: 11751993)
Ann Neurol. 2005 Nov;58(5):706-19. (PMID: 16173073)
J Am Soc Nephrol. 2002 Apr;13(4):928-36. (PMID: 11912252)
Front Cell Neurosci. 2018 Jun 21;12:173. (PMID: 29977191)
J Biol Chem. 1989 Oct 25;264(30):18041-51. (PMID: 2808363)
Exp Neurol. 2005 Dec;196(2):352-64. (PMID: 16154567)
Glia. 2001 Oct;36(1):58-67. (PMID: 11571784)
J Neurotrauma. 2005 Mar;22(3):382-97. (PMID: 15785233)
Atherosclerosis. 2011 May;216(1):83-9. (PMID: 21367419)
Am J Pathol. 2000 Sep;157(3):905-18. (PMID: 10980130)
J Neurotrauma. 2004 Dec;21(12):1831-46. (PMID: 15684772)
Kidney Int. 2004 Nov;66(5):1838-48. (PMID: 15496154)
Am J Physiol Renal Physiol. 2000 May;278(5):F747-57. (PMID: 10807586)
Behav Brain Res. 2007 Feb 27;177(2):232-41. (PMID: 17197044)
Neurotherapeutics. 2018 Jan;15(1):60-67. (PMID: 29101668)
Neuroscience. 2008 Oct 15;156(3):498-514. (PMID: 18786615)
Rheumatology (Oxford). 2009 Mar;48(3):293-8. (PMID: 19168833)
J Neuroinflammation. 2008 Jun 25;5:26. (PMID: 18578885)
Atherosclerosis. 2010 Mar;209(1):241-7. (PMID: 19772962)
Grant Information:
NS43428-01 United States NS NINDS NIH HHS
Substance Nomenclature:
0 (Complement C6)
0 (Complement Membrane Attack Complex)
0 (Glial Fibrillary Acidic Protein)
0 (Myelin Basic Protein)
SCR Disease Name:
Complement Component 6 Deficiency
Entry Date(s):
Date Created: 20201112 Date Completed: 20210319 Latest Revision: 20210319
Update Code:
20240105
PubMed Central ID:
PMC7659012
DOI:
10.1038/s41598-020-76441-3
PMID:
33177623
Czasopismo naukowe
Historically, the membrane attack complex, composed of complement components C5b-9, has been connected to lytic cell death and implicated in secondary injury after a CNS insult. However, studies to date have utilized either non-littermate control rat models, or mouse models that lack significant C5b-9 activity. To investigate what role C5b-9 plays in spinal cord injury and recovery, we generated littermate PVG C6 wildtype and deficient rats and tested functional and histological recovery after moderate contusion injury using the Infinite Horizon Impactor. We compare the effect of C6 deficiency on recovery of locomotor function and histological injury parameters in PVG rats under two conditions: (1) animals maintained as separate C6 WT and C6-D homozygous colonies; and (2) establishment of a heterozygous colony to generate C6 WT and C6-D littermate controls. The results suggest that maintenance of separate homozygous colonies is inadequate for testing the effect of C6 deficiency on locomotor and histological recovery after SCI, and highlight the importance of using littermate controls in studies involving genetic manipulation of the complement cascade.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies